Litigation Details for UNITED HEALTHCARE SERVICES, INC. v. CELGENE CORPORATION (D.N.J. 2020)

UNITED HEALTHCARE SERVICES, INC. v. CELGENE CORPORATION (D.N.J. 2020)

Docket		Date Filed	2020-12-08
Court	District Court, D. New Jersey	Date Terminated
Cause	15:2 Antitrust Litigation	Assigned To
Jury Demand	Plaintiff	Referred To
Patents	6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 7,119,106; 7,141,018; 7,189,740; 7,230,012; 7,465,800; 7,468,363; 7,668,730; 7,855,217; 7,959,566; 7,968,569; 8,204,763; 8,288,415; 8,315,886; 8,404,717; 8,530,498; 8,626,531; 8,648,095; 8,741,929; 9,056,120; 9,101,621; 9,101,622
Link to Docket	External link to docket

Biologic Drugs cited in UNITED HEALTHCARE SERVICES, INC. v. CELGENE CORPORATION

Details for UNITED HEALTHCARE SERVICES, INC. v. CELGENE CORPORATION (D.N.J. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-03-05	1		to a patient while Thalomid ‘501 Patent 6,045,501 28-Aug- 4-Apr-00 28-Aug- preventing…501 patent, the ‘976 patent, the ‘432 patent, the ‘984 patent, the ‘763 patent, the ‘188 patent, the…720 patent, the ‘977 patent, the ‘784 patent, the ‘399 patent, the ‘018 patent, the ‘566 patent, the…501 patent, the ‘976 patent, the ‘432 patent, the ‘763 patent, the ‘188 patent, the ‘720 patent, the…569 patent, the ‘363 patent, the ‘929 patent, the ‘717 patent, the ‘095 patent, the ‘120 patent, the	External link to document